CAXTON ASSOCIATES LP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$90,403
-70.4%
56,151
-46.8%
0.01%
-71.7%
Q1 2023$305,869
-53.3%
105,472
-47.2%
0.05%
+4.5%
Q4 2022$654,970
-12.1%
199,686
+1.4%
0.04%
-55.6%
Q3 2022$745,000
+668.0%
197,026
+1483.2%
0.10%
+1000.0%
Q2 2022$97,00012,4450.01%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders